Telomere length variation and telomerase activity expression in patients with congenital and acquired aplastic anemia

Acta Haematologica

Volumn 111, Issue 3, 2004, Pages 125-131

  Polychronopoulou, Sophia ^a   Koutroumba, Paraskevi ^a  

^a AGHIA SOPHIA CHILDREN S HOSPITAL   (Greece)

Author keywords

Acquired aplastic anemia; Dyskeratosis congenita; Fanconi anemia; Telomerase activity; Telomere length

Indexed keywords

NUCLEOPROTEIN; RIBOSOME RNA;

ACUTE MYELOBLASTIC LEUKEMIA; AMINO ACID SEQUENCE; APLASTIC ANEMIA; AUTOSOMAL DOMINANT INHERITANCE; CELL DIVISION; CELL POPULATION; CHROMOSOME BREAKAGE; CORRELATION FUNCTION; DISEASE SEVERITY; DYSKERATOSIS CONGENITA; ENZYME ACTIVITY; FANCONI ANEMIA; GENE SEQUENCE; GENETIC LINKAGE; GENETIC VARIABILITY; HEMATOPOIETIC STEM CELL; HUMAN; LEUKOCYTE; MOLECULAR EVOLUTION; MONONUCLEAR CELL; MYELODYSPLASTIC SYNDROME; NONHUMAN; PREMATURITY; PRIORITY JOURNAL; RECESSIVE INHERITANCE; REVIEW; RNA PROCESSING; SENESCENCE; TELOMERE; TISSUE REGENERATION; X CHROMOSOME LINKAGE; X CHROMOSOME LINKED DISORDER;

ANEMIA, APLASTIC; DYSKERATOSIS CONGENITA; FANCONI ANEMIA; HUMANS; TELOMERASE; TELOMERE;

EID: 1842509252     PISSN: 00015792     EISSN: None     Source Type: Journal    
DOI: 10.1159/000076519     Document Type: Review

References (43)

1. Blackburn EH: Structure and function of telomeres. Nature 1991;350:569-573.
2. Greider CW: Telomeres do D-loop-T-loop. Cell 1999;97:419-422.
3. Greider CW: Telomeres, telomerase and senescence. Bioessays 1990;12:363-369.
4. Harley CB: Telomere loss: Mitotic clock or genetic time bomb? Mutation Res 1991;256:271-282.
5. Morin GB: The human terminal telomere transferase enzyme is a ribonucleoprotein that synthesizes TTTAAG repeats. Cell 1989;59:521-529.
6. Cooke HJ, Smith BA: Variability at the telomeres of the human X/Y pseudoautosomal region. Cold Spring Harb Symp Quant Biol 1986;51:213-219.
7. Hiyama K, Hirai Y, Koizumi S, Akiyama M, Hiyama E, Piatyszek MA, Shay JW, Ishioka S, Yamakodo M: Activation of telomerase in human lymphocytes and hematopoietic progenitor cells. J Immunol 1995;155:3711-3715.
8. Hastie ND, Dempster M, Dunlop MG, Thompson AM, Green DK, Allshire RC: Telomere reduction in human colorectal carcinoma and with ageing. Nature 1990;346:866-868.
9. Kim S, Kaminker P, Campisi J: Telomeres, aging and cancer. In search of a happy ending. Oncogene 2002;21:503-511.
10. Ohyashiki JH, Sashida G, Tauchi T, Ohyashiki K: Telomeres and telomerase in haematologic neoplasia. Oncogene 2002;21:680-687.
11. Ball SE, Gibson FM, Rizzo S, Tooze JA, Marsh JC, Gordon-Smith EC: Progressive telomere shortening in aplastic anemia. Blood 1998;91:3582-3592.
12. Shen JB, Tang JY, Zhao JC, Pan C, Chen J, Zhou X, Wang YP: Telomerase activity and its correlation with the proliferative potential of bone marrow in aplastic anemia in children. Acta Haematol 2002;107:208-212.
13. Saldanha SN, Andrews LG, Tollefsbol TO: Analysis of telomerase activity and detection of its catalytic subunit, hTERT. Anal Biochem 2003;315:1-21.
14. Vulliamy T, Marrone A, Dokal I, Mason PJ: Association between aplastic anaemia and mutations in telomerase RNA. Lancet 2002;359:2168-2170.
15. Calado RT, Pintao MC, Silva WA Jr, Falcao RP, Zago MA: Aplastic anaemia and telomerase RNA mutations. Lancet 2002;360:1608.
16. Young NS: The etiology of acquired aplastic anemia. Rev Clin Exp Hematol 2000;4:236-259.
17. Philpott NJ, Scopes J, Marsh JC, Gordon-Smith EC, Gibson FM: Increased apoptosis in aplastic anemia bone marrow progenitor cells: Possible pathophysiologic significance. Exp Hematol 1995;23:1642-1648.
18. Young NS: Immune pathophysiology of acquired aplastic anaemia. Eur J Haematol 1996;57(suppl):55-59.
19. Brummendorf TH, Maciejewski JP, Mak J, Young NS, Lansdorp PM: Telomere length in leukocyte subpopulation of patients with aplastic anemia. Blood 2001;97:895-900.
20. Butturini A, Gale R, Verlander P, Adler-Brecher B, Gillio A, Auerbach A: Hematologic abnormalities in Fanconi anemia: An International Fanconi Anemia Registry study. Blood 1994;84:1650-1655.
21. Leteurtre F, Li X, Guardiola P, Le Roux G, Sergere JC, Richard P, Carosella ED, Gluckman E: Accelerated telomere shortening and telomerase activation in Fanconi's anaemia. Br J Haematol 1999;105:883-893.
22. Hanson H, Mathew CG, Docherty Z, Mackie Ogilvie C: Telomere shortening in Fanconi anaemia demonstrated by a direct FISH approach. Cytogenet Cell Genet 2001;93:203-206.
23. Adelfalk C, Lorenz M, Serra V, von Zglinicki T, Hirsch-Kauffmann M, Schweiger M: Accelerated telomere shortening in Fanconi anemia fibroblasts - A longitudinal study. FEBS Lett 2001;506:22-26.
24. Callen E, Samper E, Ramirez MJ, Creus A, Marcos R, Ortega JJ, Olive T, Badell I, Blasco MA, Surralles J: Breaks at telomeres and TRF2-independent end fusions in Fanconi anemia. Hum Mol Genet 2002;11:439-444.
25. Rosselli F, Ridet A, Soussi T, Duchaud E, Alapetite C, Moustacchi E: p53-dependent pathway of radio-induced apoptosis is altered in Fanconi anemia. Oncogene 1995;10:9-17.
26. Ridet A, Guillouf C, Duchaud E, Cundari E, Fiore M, Moustacchi E, Rosselli F: Deregulated apoptosis is a hallmark of the Fanconi anemia syndrome. Cancer Res 1997;57:1722-1730.
27. Dokal I: Dyskeratosis congenita in all its forms. Br J Haematol 2000;110:768-779.
28. Dokal I: Dyskeratosis congenita. A disease of premature aging. Lancet 2001;358(suppl):S27.
29. Knight SW, Heiss NS, Vulliamy TJ, Aalfs CM, McMahon C, Richmond P, Jones A, Hennekam RC, Poustka A, Mason PJ, Dokal I: Unexplained aplastic anaemia, immunodeficiency and cerebellar hypoplasia (Hoyeraal-Hreidarsson syndrome) due to mutations in the dyskeratosis congenita gene, DKC1. Br J Haematol 1999;107:335-339.
30. Yaghmai R, Kimyai-Asadi A, Rostamiani K, Heiss NS, Poustka A, Eyaid W, Bodurtha J, Nousari HC, Hamosh A, Metzenberg A: Overlap of dyskeratosis congenita with the Hoyeraal-Hreidarsson syndrome. J Pediatr 2000;136:390-393.
31. Mason PJ: Stem cells, telomerase and dyskeratosis congenita. Bioessays 2003;25:126-133.
32. Connor JM, Gatherer D, Gray FC, Pirrit LA, Affara NA: Assignment of the gene for dyskeratosis congenita to Xq28. Hum Genet 1986;72:348-351.
33. Heiss NS, Knight SW, Vulliamy TJ, Klauck SM, Wiemann S, Mason PJ, Poustka A, Dokal I: X-linked dyskeratosis congenita is caused by mutations in a highly conserved gene with putative nucleolar functions. Nat Genet 1998;19:32-38.
34. Knight SW, Vulliamy TJ, Morgan B, Devriendt K, Mason PJ, Dokal I: Identification of novel DKC1 mutations in patients with dyskeratosis congenita: Implications for pathophysiology and diagnosis. Hum Genet 2001;108:299-303.
35. Lafontaine DL, Bousquet-Antonelli C, Henry Y, Caizergues-Ferrer M, Tollervey D: The box H + ACA snoRNAs Cbf5p, the putative rRNA pseudouridine synthase. Genes Dev 1998;12:527-537.
36. Spedaliere CJ, Hamilton CS, Mueller EG: Functional importance of motif I of pseudouridine synthases: Mutagenesis of aligned lysine and proline residues. Biochemistry 2000;39:9459-9465.
37. Mitchell JR, Wood E, Collins K: A telomerase component is defective in the human disease dyskeratosis congenita. Nature 1999;402:551-555.
38. Vulliamy TJ, Knight SW, Mason PJ, Dokal I: Very short telomeres in the peripheral blood of patients with X-linked and autosomal dyskeratosis congenita. Blood Cells Mol Dis 2001;27:353-357.
39. Ruggero D, Grisendi S, Piazza F, Rego E, Mari F, Rao PH, Cordon-Cardo C, Pandolfi PP: Dyskeratosis congenita and cancer in mice deficient in ribosomal RNA modification. Science 2003;299:259-262.
40. Vulliamy T, Marrone A, Goldman F, Dearlove A, Bessler M, Mason PJ, Dokal I: The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita. Nature 2001;413:432-435.
41. Comolli LR, Smirnov I, Xu L, Blackburn EH, James TL: A molecular switch underlies a human telomerase disease. Proc Natl Acad Sci USA 2002;99:16998-17003.
42. Theimer CA, Finger LD, Trantirek L, Feigon J: Mutations linked to dyskeratosis congenita cause changes in the structural equilibrium in telomerase RNA. Proc Natl Acad Sci USA 2003;100:449-454.
43. Elliott AM, Graham GE, Bernstein M, Mazer B, Teebi AS: Dyskeratosis congenita: An autosomal recessive variant. Am J Med Genet 1999;83:178-182.